Results 211 to 220 of about 3,759,449 (356)
Research, Data, and Evidence-Based Treatment Use in State Behavioral Health Systems, 2001-2012.
E. Bruns +5 more
semanticscholar +1 more source
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham +21 more
wiley +1 more source
Global health in the face of 'permacrises': why primary health care matters. [PDF]
Omam LA, Nkengateh AN, Mba CM.
europepmc +1 more source
Family planning programs in sub-Saharan Africa [PDF]
In the 1980s, signs that sub-Saharan Africans would welcome family planning in numbers sufficient to make a difference in fertility rates were scattered and weak.
Lauro, Donald +3 more
core
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan +9 more
wiley +1 more source
Using Queer Theory to Advance Understandings of 'Queer Caregiving' With LGBTQ+ Older Adults. [PDF]
Hall S, Oswald A.
europepmc +1 more source
Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts +8 more
wiley +1 more source
TB and primary health care: a synergistic pathway to universal health coverage. [PDF]
Pedrazzoli D +5 more
europepmc +1 more source
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira +14 more
wiley +1 more source
Medical specialists in LMICs: a systematic review and best-fit framework synthesis of the evidence on their roles and contribution to health systems. [PDF]
Russo G +5 more
europepmc +1 more source

